These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23046799)

  • 1. Distribution of human papillomavirus types, cervical cancer screening history, and risk factors for infection in Manitoba.
    Demers AA; Shearer B; Severini A; Lotocki R; Kliewer EV; Stopera S; Wong T; Jayaraman G
    Chronic Dis Inj Can; 2012 Sep; 32(4):177-85. PubMed ID: 23046799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
    Flores Y; Shah K; Lazcano E; Hernández M; Bishai D; Ferris DG; Lörincz A; Hernández P; Salmerón J;
    Salud Publica Mex; 2002; 44(4):335-44. PubMed ID: 12216521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital-based prevalence and sensitivity of high-risk human papillomavirus in Thai urban population.
    Suwannarurk K; Tapanadechopol P; Pattaraarchachai J; Bhamarapravati S
    Cancer Epidemiol; 2009 Jul; 33(1):56-60. PubMed ID: 19679049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic human papillomavirus infection and cervical lesions in aboriginal women of Nunavut, Canada.
    Healey SM; Aronson KJ; Mao Y; Schlecht NF; Mery LS; Ferenczy A; Franco EL
    Sex Transm Dis; 2001 Dec; 28(12):694-700. PubMed ID: 11725224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania.
    Şuteu O; Blaga ML; Nygård M; Leinonen MK; Nicula F; Păiş R; Coza D; Cadariu PA; Melnic A; Andreassen T; Hashim D; Weiderpass E
    Eur J Cancer Prev; 2020 Mar; 29(2):141-148. PubMed ID: 31033568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Human Papilloma Virus (HPV), cervical cancer incidence and screening uptake: differences among Northern, Central and Southern Italy].
    Giorgi Rossi P; Chini F; Borgia P; Guasticchi G; Carozzi FM; Confortini M; Angeloni C; Buzzoni C; Buonaguro FM;
    Epidemiol Prev; 2012; 36(2):108-19. PubMed ID: 22706361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
    Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
    J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer.
    Song T; Seong SJ; Lee SK; Kim BR; Ju W; Kim KH; Nam K; Sim JC; Kim TJ
    J Obstet Gynaecol; 2020 Feb; 40(2):240-246. PubMed ID: 31340702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary high-risk HPV screening for cervical cancer in post-menopausal women.
    Gyllensten U; Gustavsson I; Lindell M; Wilander E
    Gynecol Oncol; 2012 May; 125(2):343-5. PubMed ID: 22293044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results and cost evaluation of triage with high risk HPV test in cervical cancer screening. A pilot study in Piedmont (North-West Italy)].
    Magnani C; Gillio Tos A; De Marco L; Calvia M; Cipelletti A; Bestagini P; Pagano E; Segnan N; Ronco G
    Epidemiol Prev; 2012; 36(2):88-94. PubMed ID: 22706358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of genital human papillomavirus infection in a female adolescent population.
    Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
    Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer.
    Gyllensten U; Sanner K; Gustavsson I; Lindell M; Wikström I; Wilander E
    Br J Cancer; 2011 Aug; 105(5):694-7. PubMed ID: 21811250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea.
    Oh JK; Franceschi S; Kim BK; Kim JY; Ju YH; Hong EK; Chang YC; Rha SH; Kim HH; Kim JH; Kim CY; Shin HR
    Eur J Cancer Prev; 2009 Feb; 18(1):56-61. PubMed ID: 19077566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of high-risk HPV types and abnormal cervical cytology in American Indian/Alaska Native women, 2003-2005.
    Alfonsi GA; Datta SD; Mickiewicz T; Koutsky LA; Ghanem K; Hagensee M; Kerndt P; Hsu K; Weinstock H; Shlay JC
    Public Health Rep; 2011; 126(3):330-7. PubMed ID: 21553660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Papillomavirus Genotyping Testing Practice in 2014: Results of a College of American Pathologists National Survey.
    Zhao C; Crothers BA; Ghofrani M; Li Z; Souers RJ; Hussain M; Fan F; Ocal IT; Goodrich K; Shen R; Davey DD;
    Arch Pathol Lab Med; 2016 Dec; 140(12):1364-1370. PubMed ID: 27479334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papilloma virus infection of uterine cervix and spectrum of cervical pathology in human immunodeficiency virus/AIDS.
    Jain BB; Adhikary T; Sadhukhan PC; Nandi A
    J Cancer Res Ther; 2021; 17(6):1462-1467. PubMed ID: 34916378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invader human papillomavirus (HPV) type 16 and 18 assays as adjuncts to HPV screening of cervical papanicolaou smears with atypical squamous cells of undetermined significance.
    Wong AK; Chan RC; Nichols WS; Bose S
    Cancer; 2009 Feb; 115(4):823-32. PubMed ID: 19127558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005.
    Datta SD; Koutsky LA; Ratelle S; Unger ER; Shlay J; McClain T; Weaver B; Kerndt P; Zenilman J; Hagensee M; Suhr CJ; Weinstock H
    Ann Intern Med; 2008 Apr; 148(7):493-500. PubMed ID: 18378945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for cervical human papillomavirus infection and high-grade intraepithelial lesion in women aged 20 to 31 years in Germany.
    Remschmidt C; Kaufmann AM; Hagemann I; Vartazarova E; Wichmann O; Deleré Y
    Int J Gynecol Cancer; 2013 Mar; 23(3):519-26. PubMed ID: 23360813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and carcinogenic risk of high-risk human papillomavirus subtypes in different cervical cytology: a study of 124,251 cases from the largest academic center in China.
    Tao X; Zhang H; Wang S; Chen T; Cong Q; Wang L; Zhou X; Zhao C
    J Am Soc Cytopathol; 2021; 10(4):391-398. PubMed ID: 33906830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.